Literature DB >> 19638711

Clinical profiles of adult patients with single ventricular physiology.

Noriko Motoki1, Hideo Ohuchi, Aya Miyazaki, Osamu Yamada.   

Abstract

BACKGROUND: This study was performed to clarify the present global clinical status, including medication(s) and social abilities, of adult patients with single ventricular physiology (SVP). METHODS AND
RESULTS: Clinical charts were retrospectively reviewed to evaluate the global clinical status, including functional capacity, medication(s), complications, and social activities of 68 adult patients with SVP aged 20-53 years (41 males); 50 had undergone the Fontan operation and they were divided into the young adult (25 patients) and adult Fontan groups. The others were cyanotic patients without the Fontan operation (non-Fontan group). Although the Fontan groups showed better functional capacity, higher arterial oxygen saturation and brain natriuretic peptide levels, and a better renal function, there was no difference in the cardiovascular events during follow-up between the 3 groups. The most frequent complication was arrhythmia without a significant group difference, although the non-Fontan group showed a high percentage of heart failure. Only 41 patients (60%) had a job and 8 (12%) were married.
CONCLUSIONS: Although the Fontan groups had favorable pathophysiological conditions, the high rate of cardiovascular events, as well as unsatisfactory social situations, indicate the importance of meticulous life-long management of patients with SVP, regardless of the type of surgical intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19638711     DOI: 10.1253/circj.cj-08-1155

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  7 in total

Review 1.  Stem cell therapies in patients with single ventricle physiology.

Authors:  Suguru Tarui; Shunji Sano; Hidemasa Oh
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Apr-Jun

2.  Clinical profile of the adolescent/adult Fontan survivor.

Authors:  Nancy A Pike; Lorraine S Evangelista; Lynn V Doering; Deborah Koniak-Griffin; Alan B Lewis; John S Child
Journal:  Congenit Heart Dis       Date:  2011 Jan-Feb       Impact factor: 2.007

3.  Risk factors and serological markers of liver cirrhosis after Fontan procedure.

Authors:  Mikiko Shimizu; Kenji Miyamoto; Yunosuke Nishihara; Gaku Izumi; Shuji Sakai; Kei Inai; Toshio Nishikawa; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2015-09-19       Impact factor: 2.037

Review 4.  The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Authors:  Massimiliano Cantinotti; Yuk Law; Simona Vittorini; Maura Crocetti; Marotta Marco; Bruno Murzi; Aldo Clerico
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

5.  Galectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation.

Authors:  Alexander R Opotowsky; Fernando Baraona; Justin Owumi; Brittani Loukas; Michael N Singh; Anne Marie Valente; Fred Wu; Susan Cheng; Gruschen Veldtman; Eric B Rimm; Michael J Landzberg
Journal:  J Am Heart Assoc       Date:  2016-01-11       Impact factor: 5.501

6.  Identification of metabolomic profile related to adult Fontan pathophysiology.

Authors:  Noriko Motoki; Hirohiko Motoki; Masafumi Utsumi; Shoko Yamazaki; Haruka Obinata; Kohta Takei; Satoshi Yasukochi
Journal:  Int J Cardiol Heart Vasc       Date:  2021-11-24

7.  Fontan Circulation Associated Organ Abnormalities Beyond the Heart, Lungs, Liver, and Gut: A Systematic Review.

Authors:  Evi Ritmeester; Veerle A Veger; Jelle P G van der Ven; Gabrielle M J W van Tussenbroek; Carine I van Capelle; Floris E A Udink Ten Cate; Willem A Helbing
Journal:  Front Cardiovasc Med       Date:  2022-03-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.